With that as a backdrop, let's consider four excellent income stocks that investors can buy amid the current sell-off: AbbVie(NYSE: ABBV), Amgen(NASDAQ: AMGN), Bristol Myers Squibb(NYSE: BMY), and ...

Complete Genomics, a leading innovator in genomic sequencing announced a collaboration with Velsera, a leading global healthcare technology company, to deliver an end-to-end genetic testing solution ...

While most people will agree about holding traditional assets like stocks and bonds in their portfolios, hedge funds are more ...

Investor sentiment entering 2025 was upbeat. US equities again outperformed global peers in 2024, and hopes were high that ...

Rob Burdett is head of multi-manager at Nedgroup. He joined the company last year after leaving Columbia Threadneedle where ...

One story from the recent past that helps understand the dramatic impacts technology can have on our experience of work.

Whilst we view our 10% annualized return as a solid performance, we are still working on achieving our stated goal of a ...

We see some evidence of this in the ... ramp up spending when necessary (for example, adapting to the demand uptick in e-bikes). Further, we believe the company’s capital expenditures have ...

Microbes can also interact with enteroendocrine cells (EECs) present in the gut lining to send hormones throughout the body.

Dividend yield is a ratio that demonstrates a ... Historical evidence suggests that focusing on dividends may amplify returns rather than slow them down. For example, according to analysts at ...

Albanese’s prime ministership has been slow but steady. If he’s re-elected, he will need to give Australians a more ambitious ...